“We’re framing today as a relatively simple debate — perhaps an overly simple one,” began I. Glenn Cohen, Deputy Dean and Professor at Harvard Law School and Faculty Director of the Petrie-Flom Center, as he opened the Center’s recent event, Toward Psychedelics Access: Go Faster or Slower?
The case for a new international human rights treaty for older persons is clear. In much of the world, older persons represent ever-larger shares of the population. The World Health Organization estimates the number of people aged over 60 will double by 2050.
“People around the world are living longer, including our elected officials and judges,” remarked Petrie-Flom Center Executive Director Susannah Baruch as she opened the Center’s recent event, “How Old Is Too Old to Govern?”
The background of the case, the contents of the draft opinion, and potential implications for abortion access and other rights.
Key takeaways from a virtual panel discussion with three leading psychedelic policy advocates.
The ACLU mounted an unprecedented challenge the entire practice of gene patenting in America. And, against the odds, they won.
Orphan medicines are available for a larger number of diseases and patients than ever before.
Are the incentive mechanisms for orphan drug development working as they should?
Before we can consider ways to address excessive pricing for orphan drugs, we must first diagnose the underlying problem.
What are the most pressing priorities for developing new drugs for rare diseases, and how can legal research help meet these needs?
